Takeda India’s Dedication to Employee Well-being Earns Great Place To Work® Certification
Takeda Biopharmaceuticals India Private Limited, an R&D-driven global biopharmaceutical leader, has been certified as a Great Place To Work® in India from March 2023 to March 2024. Formerly known as Baxalta Bioscience India Pvt. Ltd., the company concentrates its research and development efforts on Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI).
The certification is granted by the Great Place To Work® Institute, the international authority on workplace culture. The Institute serves businesses, non-profits, and government agencies across 60 countries, conducting extensive research on the attributes of exceptional workplaces for more than three decades.
In India, the Great Place To Work® Institute partners with over 1400 organizations annually across 22 industries to assist in creating High-Trust, High-Performance Cultures. Takeda India’s certification highlights its dedication to providing a work environment that promotes employee engagement, satisfaction, and professional development.
Takeda’s employees are committed to enhancing patients’ quality of life and collaborating with healthcare partners in nearly 80 countries and regions. The Great Place to Work® certification in India serves as a testament to Takeda’s focus on fostering a culture that supports employee well-being and embodies the company’s mission and values.